Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

borderline significantP = .0621.2× alphagold
15 , 17 , 45 By this method, R304Q displays a borderline significant reduced interaction compared with wild-type AIP ( P = .062). 45 In a different study, the expression of phosphodiesterase 4A4 (PDE4A4) and phosphodiesterase 4A8 (PDE4A8) were analysed in human somatotrophinomas with confocal microscopy and immunofluorescence. 32 AIP mut-positive PitNETs were associated with low levels of PDE4A4 and PDE4A8 expression.
borderline significantP = 0.0621.2× alphagold
Multivariate Cox proportional hazards regression analyses further confirmed that age (HR = 2.687; 95%CI = 1.156–6.244; P = 0.022) and EBV DNA (HR = 3.269; 95%CI = 1.383–7.728; P = 0.007) were highly significant prognostic factors for OS, and SUV max of patients with distant recurrence was borderline significant (HR = 2.415; 95%CI = 0.956–6.101; P = 0.062).
borderline significantp = 0.0621.2× alphagold
Additionally, the reduction observed between the more than 3 month‐ and beyond 15‐month follow‐up periods was borderline significant (5/16 or 31.25%, p = 0.062) (Table 4 ). 4 Discussion This study identified three key factors associated with higher GSI scores following phenol–croton oil peeling: full‐face treatment, older patient age, and the absence of cutaneous side effects.
borderline significantP = 0.0621.2× alphagold
Similarly, a significant difference was also seen in the OS between the DC and CC groups (median OS: 26.0 vs 73.0 mo, P < 0.001), but there was only a borderline significant survival difference between the PDC and DC groups (median OS: 52.0 vs 26.0 mo, P = 0.062).
borderline significantp = 0.0621.2× alphagold
Cytokine release in laquinimod‐treated non‐stimulated monocytes Monocytes from HV showed at least borderline significant evidence for an increase in Th1‐activating cytokine IL‐12 ( p = 0.062) (Figure S1) and the Th2‐activating cytokines IL‐4 ( p = 0.009) and IL‐5 ( p = 0.002) (Figure S2), after 2hPT with 1 μM laquinimod.
borderline significantp=0.0621.2× alphagold
Among the other variables tested individually in the Cox regression, we found that: (i) the whole brain T1 hypointense lesion load was significantly associated with TTE (p=0.04, HR 1.00004, 95% CI 1.000001 to 1.00007); for every extra ml in total T1 lesion load, the time taken to reach the event was reduced by 0.5%; and (ii) there was a borderline significant association between gender and TTE (p=0.062, HR 1.62, 95% CI 0.96 to 2.73); the time taken for men to reach the event was reduced by 60%.
borderline significantP =0.0621.2× alphagold
A Portuguese study from 2018 on 30 patients with BrS and an ICD implanted found that 53.3% of the included patients had taken a nonrecommended drug, and that 6 out of 7 patients (85.7%) who had experienced appropriate ICD therapies had received a nonrecommended drug as opposed to 45.4% of patients without ICD therapies (difference borderline significant, P =0.062). 4 The authors found a mean time between therapies and unsafe drug use of 3.8±7.5 days.
borderline significantP = .0621.2× alphagold
The changes (mean ± SD) in K trans (ie, r K trans Δ1-0 and r K trans Δ2-0 ) values were 91% ± 104% and 33% ± 70%, respectively, and were significantly different ( P = .048), whereas r K trans Δ2-1 decreased by −20% ± 42%, and showed a borderline significant difference from that of r K trans Δ1-0 ( P = .062).
borderline significantp = 0.06201.2× alphagold
While the SLFN11 H-score assessed in cancer cells showed only a borderline significant association (HR = 0.62, 95% confident interval (CI) = 0.38–1.02, p = 0.0620), overall and non-cancer higher SLFN11 H-scores were strongly associated with longer progression-free interval (PFI) by univariable analysis (HR = 0.50, 95% CI = 0.33–0.75, p = 0.0009; and HR = 0.54, 95% CI = 0.36–0.81, p = 0.0028, respectively).
borderline significantp = 0.0621.2× alphagold
Association between maternal pre-pregnancy BMI, placental EtP, and cord blood metabolic biomarkers The difference in mean log-transformed placental EtP values between the groups of mothers with underweight/normal pre-pregnancy BMI (0.13 ± 1.08) kg/m 2 and overweight/obese pre-pregnancy BMI (-0.15 ± 1.10) kg/m 2 was borderline significant (p = 0.062).